Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25850693 | 0.79 | — | — | |
| SCHEMBL14094680 | 0.76 | KDM4E (0.44) | KDM4ECYP2D6LMNAHSD17B10 | |
| SCHEMBL17381349 | 0.76 | LMNA (0.41) | LMNAHSD17B10 | |
| SCHEMBL23868445 | 0.74 | LMNA (0.33) | LMNAHSD17B10 | |
| SCHEMBL20415943 | 0.74 | — | — | |
| SCHEMBL21740369 | 0.73 | — | — | |
| SCHEMBL22340364 | 0.73 | LMNA (0.47) | LMNAHSD17B10 | |
| SCHEMBL21083165 | 0.72 | ACLY (0.37) | KDM4E | |
| SCHEMBL22340464 | 0.71 | — | — | |
| SCHEMBL22340346 | 0.71 | LMNA (0.34) | LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200054739-A1 | CONJUGATED VACCINES | SUTROVAX, INC. | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200054739-A1 | CONJUGATED VACCINES | ASNS, CD14, CD74 | KDM4E 4357/4885CYP2D6 3425/4885LMNA 4333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.